CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,323,510
- in 6 filings, $5.0M under 10b5-1 plans
Net −$7,323,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-28 | Radovich Peter Chief Operating Officer | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2020-03-20 | Tucker Edwin Jonathan Chief Medical Officer | Purchase | +2,500 | $11.90 | $30K | 6,000 |
| 2020-03-19 | Tucker Edwin Jonathan Chief Medical Officer | Purchase | +2,000 | $9.91 | $20K | 3,500 |
| 2020-01-10 | Vig Pamela Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +52,000 | 52,000 | ||
| 2020-01-10 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-10 | Longpre Lara Chief Development Officer | Grant or award · Stock Option (right to buy) | +52,000 | 52,000 | ||
| 2020-01-10 | Clements Ian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2020-01-10 | Peetz Christopher President and CEO | Grant or award · Stock Option (right to buy) | +170,000 | 170,000 | ||
| 2020-01-07 | Longpre Lara Chief Development Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2020-01-01 | GREY MICHAEL G Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-10-24 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-09-17 | Fischer Laurent Director | Purchase | +1,648 | $9.37 | $15K | 6,750 |
| 2019-09-16 | Fischer Laurent Director | Purchase | +452 | $9.47 | $4K | 5,102 |
| 2019-09-10 | Longpre Lara CHIEF DEVELOPMENT OFFICER | Purchase | +965 | $10.64 | $10K | 105,372 |
| 2019-09-10 | Brege Laura Director | Purchase | +10,000 | $11.22 | $112K | 10,000 |
| 2019-09-10 | Fischer Laurent Director | Purchase | +960 | $10.29 | $10K | 4,650 |
| 2019-09-09 | Peetz Christopher President and CEO | Purchase | +2,000 | $10.90 | $22K | 194,250 |
| 2019-09-09 | Peetz Christopher President and CEO | Purchase | +2,320 | $11.35 | $26K | 196,570 |
| 2019-09-09 | Fischer Laurent Director | Purchase | +1,670 | $10.54 | $18K | 3,390 |
| 2019-09-09 | Fischer Laurent Director | Purchase | +300 | $11.30 | $3K | 3,690 |
Page 31 of 32 · 635 trades